Point72 Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$266K Buy
2023
Q2
Sell
2023
Q1
$20.7K Buy